Free Trial
NASDAQ:TMCI

Treace Medical Concepts Q1 2025 Earnings Report

Treace Medical Concepts logo
$6.56 -0.06 (-0.91%)
As of 01:24 PM Eastern

Treace Medical Concepts EPS Results

Actual EPS
N/A
Consensus EPS
-$0.31
Beat/Miss
N/A
One Year Ago EPS
N/A

Treace Medical Concepts Revenue Results

Actual Revenue
N/A
Expected Revenue
$52.07 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Treace Medical Concepts Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 6, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Remove Ads
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Treace Medical Concepts? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Treace Medical Concepts and other key companies, straight to your email.

About Treace Medical Concepts

Treace Medical Concepts (NASDAQ:TMCI), a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

View Treace Medical Concepts Profile

More Earnings Resources from MarketBeat